Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis

Corinna Schmitz, Heidi Noels, Omar El Bounkari, Eva Straussfeld, Remco T. A. Megens, Marieke Sternkopf, Setareh Alampour-Rajabi, Christine Krammer, Pathricia V. Tilstam, Norbert Gerdes, Christina Burger, Aphrodite Kapurniotu, Richard Bucala, Joachim Jankowski, Christian Weber, Juergen Bernhagen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4428-4443
Number of pages16
JournalFaseb Journal
Volume32
Issue number8
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • lymphocyte
  • chemokine
  • immunology
  • antibody
  • MIGRATION INHIBITORY FACTOR
  • B-CELL SURVIVAL
  • REDUCES ATHEROSCLEROSIS
  • IMMUNE-COMPLEXES
  • OXIDIZED LDL
  • T-CELLS
  • MICE
  • BAFF
  • ANTIBODIES
  • RECEPTORS

Cite this

Schmitz, C., Noels, H., El Bounkari, O., Straussfeld, E., Megens, R. T. A., Sternkopf, M., Alampour-Rajabi, S., Krammer, C., Tilstam, P. V., Gerdes, N., Burger, C., Kapurniotu, A., Bucala, R., Jankowski, J., Weber, C., & Bernhagen, J. (2018). Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. Faseb Journal, 32(8), 4428-4443. https://doi.org/10.1096/fj.201800058R